NasdaqGS:IDXXMedical Equipment
Assessing IDEXX Laboratories (IDXX) Valuation After Strong 2025 Earnings Beat And 2026 Growth Guidance
IDEXX Laboratories (IDXX) is back in focus after reporting fourth quarter and full year 2025 results that topped analyst expectations, paired with fresh 2026 guidance outlining revenue and earnings growth targets.
See our latest analysis for IDEXX Laboratories.
Despite the upbeat fourth quarter and 2026 outlook, IDEXX Laboratories’ recent share price performance has cooled. The 7 day share price return is 8.95% and the 90 day share price return is 12.17%, set against a 1 year total...